A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS

Clinical trial NCT03283397 · TERMINATED

Trial details

NCT number: NCT03283397
Sponsor: Bosnalijek D.D
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2019-03-26
Primary completion: 2023-07-01
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.